The control of ccn2 (ctgf) gene expression in normal and scleroderma fibroblasts

Journal of Clinical Pathology - Molecular Pathology

Volumn 54, Issue 3, 2001, Pages 180-183

  Leask, A ^a   Sa, S ^a   Holmes, A ^b   Shiwen, X ^b   Black, C M ^b   Abraham, D J ^b  

^a FIBROGEN INC   (United States)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Connective tissue growth factor; Scleroderma; Transforming growth factor

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; BINDING SITE; GENE EXPRESSION; GENE MUTATION; HUMAN; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; REGULATORY MECHANISM; SCLERODERMA; SIGNAL TRANSDUCTION;

CASE-CONTROL STUDIES; DNA-BINDING PROTEINS; FIBROBLASTS; GENE EXPRESSION; GROWTH SUBSTANCES; HUMANS; IMMEDIATE-EARLY PROTEINS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MUTATION; PHENOTYPE; PROMOTER REGIONS (GENETICS); SCLERODERMA, SYSTEMIC; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 0034971702     PISSN: 13668714     EISSN: None     Source Type: Journal    
DOI: 10.1136/mp.54.3.180     Document Type: Article

References (40)

1. The aetiopathogenesis of systemic sclerosis
2. Identification of multiple, differentially expressed messenger RNAs in dermal fibroblasts from patients with systemic sclerosis
3. Role of transforming growth factor beta in human disease
4. A possible role for transforming growth factorbeta in systemic sclerosis
5. Spontaneous increase of transforming growth factor beta production by bronchoalveolar mononuclear cells of patients with systemic autoimmune diseases affecting the lung
6. Expression of TGF-beta 1, -beta 2 and -beta 3 in localized and systemic scleroderma
7. Immunocytochemical localization and serologic detection of transforming growth factor beta 1. Association with type I procollagen and inflammatory cell markers in diffuse and limited systemic sclerosis, morphea, and Raynaud's phenomenon
8. Transforming growth factor beta within fibrotic scleroderma lungs
9. Secretion and binding of transforming growth factor beta by scleroderma and normal dermal fibroblasts
10. Autocrine over-expression of CTGF maintains fibrosis: RDA analysis of fibrosis genes in systemic sclerosis
11. CCN proteins are distinct from and should not be considered members of the insulin-like growth factor-binding protein superfamily
12. Connective tissue growth factor: What's in a name?
13. Connective tissue growth factor: A cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10
14. Purification and characterization of novel heparin-binding growth factors in uterine secretory fluids. Identification as heparin-regulated Mr 10,000 forms of connective tissue growth factor
15. Connective tissue growth factor: A mediator of TGF-beta action on fibroblasts
16. Connective tissue growth factor mediates transforming growth factor beta-induced collagen synthesis: Down-regulation by cAMP
17. Inhibition of endogenous expression of connective tissue growth factor by its antisense oligonucleotide and antisense RNA suppresses proliferation and migration of vascular endothelial cells
18. Role and interaction of connective tissue growth factor with transforming growth factor-beta in persistent fibrosis: A mouse fibrosis model
19. Tumor necrosis factor alpha suppresses the induction of connective tissue growth factor by transforming growth factor-beta in normal and scleroderma fibroblasts
20. Connective tissue growth factor: A novel regulator of mucosal repair and fibrosis in inflammatory bowel disease?
21. Connective tissue growth factor is a regulator for fibrosis in human chronic pancreatitis
22. Connective tissue growth factor gene expression in tissue sections from localized scleroderma, keloid, and other fibrotic skin disorders
23. Expression of connective tissue growth factor in human renal fibrosis
24. Significant correlation between connective tissue growth factor gene expression and skin sclerosis in tissue sections from patients with systemic sclerosis
25. Levels of interleukin 12, a cytokine of type 1 helper T cells, are elevated in sera from patients with systemic sclerosis
26. A novel transforming growth factor beta response element controls the expression of the connective tissue growth factor gene
27. CTGF and SMADs: Maintenance of scleroderma phenotype is independent of SMAD signalling
28. SMADs: Mediators and regulators of TGF-beta signaling
29. Human Smad3 and Smad4 are sequence-specific transcription activators
30. TGF-beta-stimulated cooperation of smad proteins with the coactivators CBP/p300
31. TGF-beta-induced phosphorylation of Smad3 regulates its interaction with coactivator p300/CREB-binding protein
32. Factor VIIa and thrombin induce the expression of Cyr61 and connective tissue growth factor, extracellular matrix signaling proteins that could act as possible downstream mediators in factor VIIa x tissue factor-induced signal
33. Dexamethasone is a novel potent inducer of connective tissue growth factor expression. Implications for glucocorticoid therapy
34. Regulation of connective tissue growth factor expression by prostaglandin E(2)
35. Vascular endothelial growth factor induces expression of connective tissue growth factor via KDR, flt1, and phosphatidylinositol 3-kinase-akt-dependent pathways in retinal vascular cells
36. Transcriptional regulation of connective tissue growth factor by cortisol in osteoblasts
37. Identification of connective tissue growth factor as a target of WT1 transcriptional regulation
38. Identification of an RNA element that confers post-transcriptional repression of connective tissue growth factor/hypertrophic chondrocyte specific 24 (ctgf/hcs24) gene: Similarities to retroviral RNA-protein
39. Characterization of a mouse ctgf 3′-UTR segment that mediates repressive regulation of gene expression